Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled Phase 2B Clinical Protocol to Evaluate the Effect of NA-911 on Upper Extremity Motor Function Following Ischemic Stroke

Next Previous
Search
Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Phase 2B Clinical Protocol to Evaluate the Effect of NA-911 on Upper Extremity Motor Function Following Ischemic Stroke

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 21 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs NA 911 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use

    • Most Recent Events

    • 19 Aug 2024 According to a Biomed Industries media release, company unveiled new data and introduced a Phase 2 Clinical Trial protocol for its innovative stroke treatment drug, NA-911 in a paper titled Associations Between Alzheimer's Disease and Stroke: Clinical Studies of NA-831 for AD and NA-911 for Stroke was presented at the Alzheimer's Association International Conference, held from July 27 to August 1, 2024, in Philadelphia, PA, USA.
    • 19 Jun 2024 New trial record
    • 06 May 2024 According to a Biomed Industries media release, trial will be presentedat the upcoming 10th European Stroke Organization Conference (ESOC 2024), to be held from May 15th to 17th in Basel, Switzerland.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top